NFKBIA and NFKBIE encode the cytosolic NF-κB inhibitors IκBα and IκBɛ, whereas inactivating the inhibitors can result in activation of NF-Kappa-B signaling, which is a hallmark of DLBCL 25. This evidence concerns the gene NFKBIE and diffuse large B-cell lymphoma.